FDA Approved: ZIPRASIDONE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ziprasidone from Chartwell RX, LLC, enabling a generic version of the antipsychotic to be marketed. Ziprasidone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

SUPPL AP for ZIPRASIDONE (ZIPRASIDONE)